Richard Wise

4.8k total citations · 2 hit papers
94 papers, 3.4k citations indexed

About

Richard Wise is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Richard Wise has authored 94 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmacology, 20 papers in Molecular Medicine and 17 papers in Epidemiology. Recurrent topics in Richard Wise's work include Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (20 papers) and Pneumonia and Respiratory Infections (15 papers). Richard Wise is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (24 papers), Antibiotic Resistance in Bacteria (20 papers) and Pneumonia and Respiratory Infections (15 papers). Richard Wise collaborates with scholars based in United Kingdom, United States and Canada. Richard Wise's co-authors include Keith E. Livo, Todd M. Hoefen, Raymond F. Kokaly, Gregg A. Swayze, R. N. Clark, N. Brenwald, Martin J. Gill, Martin A. Safer, Stephen J. Sutley and Alasdair MacGowan and has published in prestigious journals such as The Lancet, NeuroImage and Hepatology.

In The Last Decade

Richard Wise

89 papers receiving 3.2k citations

Hit Papers

USGS Digital Spectral Library splib06a 2007 2026 2013 2019 2007 2017 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Richard Wise United Kingdom 26 839 712 684 511 452 94 3.4k
Joseph E. Cavanaugh United States 39 96 0.1× 851 1.2× 72 0.1× 385 0.8× 28 0.1× 170 5.9k
David E. Roberts United Kingdom 32 107 0.1× 167 0.2× 57 0.1× 234 0.5× 118 0.3× 165 3.4k
Seok Lee South Korea 37 75 0.1× 582 0.8× 78 0.1× 89 0.2× 62 0.1× 398 6.1k
Paul Cross United Kingdom 34 64 0.1× 296 0.4× 455 0.7× 134 0.3× 9 0.0× 162 5.1k
Michael J. Smith United States 26 172 0.2× 143 0.2× 72 0.1× 79 0.2× 10 0.0× 90 2.7k
David A. Stephens Canada 30 97 0.1× 995 1.4× 18 0.0× 709 1.4× 31 0.1× 142 4.3k
David Edwards United States 34 73 0.1× 1.1k 1.5× 512 0.7× 539 1.1× 5 0.0× 66 4.4k
James B. Campbell United States 39 68 0.1× 586 0.8× 8 0.0× 306 0.6× 609 1.3× 229 7.1k
Luc Bissonnette Canada 31 71 0.1× 115 0.2× 438 0.6× 16 0.0× 19 0.0× 113 2.9k
Xueying Wang China 39 92 0.1× 176 0.2× 20 0.0× 102 0.2× 196 0.4× 224 5.1k

Countries citing papers authored by Richard Wise

Since Specialization
Citations

This map shows the geographic impact of Richard Wise's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard Wise with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard Wise more than expected).

Fields of papers citing papers by Richard Wise

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard Wise. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard Wise. The network helps show where Richard Wise may publish in the future.

Co-authorship network of co-authors of Richard Wise

This figure shows the co-authorship network connecting the top 25 collaborators of Richard Wise. A scholar is included among the top collaborators of Richard Wise based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard Wise. Richard Wise is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gottlieb, Michael C., et al.. (2025). Red flag laws: Psychologist duties and professional responsibilities.. Professional Psychology Research and Practice. 56(1). 4–18.
2.
Kokaly, Raymond F., R. N. Clark, Gregg A. Swayze, et al.. (2017). USGS Spectral Library Version 7. Data series. 483 indexed citations breakdown →
3.
Safer, Martin A., et al.. (2016). Educating jurors about eyewitness testimony in criminal cases with circumstantial and forensic evidence. International Journal of Law and Psychiatry. 47. 86–92. 9 indexed citations
4.
Weatherly, Jeffrey N., Richard Wise, & Adam Derenne. (2012). Probability Discounting of Legal and Non-Legal Outcomes. Behavior and Social Issues. 21(1). 165–187. 4 indexed citations
5.
Wise, Richard, et al.. (2009). How to Analyze the Accuracy of Eyewitness Testimony in a Criminal Case. Journal of Family Medicine and Primary Care. 4(1). 110–6. 16 indexed citations
6.
Miller, Joseph C., et al.. (2009). Learning effects in the block design task: A stimulus parameter-based approach.. Psychological Assessment. 21(4). 570–577. 7 indexed citations
7.
Wise, Richard, et al.. (2007). A Tripartite Solution to Eyewitness Error. The Journal of Criminal Law and Criminology (1973-). 97(3). 807–872. 24 indexed citations
8.
Bulte, Daniel P., Peter A. Chiarelli, Richard Wise, & Peter Jezzard. (2007). Measurement of cerebral blood volume in humans using hyperoxic MRI contrast. Journal of Magnetic Resonance Imaging. 26(4). 894–899. 58 indexed citations
9.
Wise, Richard. (2007). An overview of the Specialist Advisory Committee on Antimicrobial Resistance (SACAR). Journal of Antimicrobial Chemotherapy. 60(suppl_1). i5–i7. 12 indexed citations
10.
Wise, Richard, et al.. (2006). Proceedings of the 4th New World Luminescence Dating and Dosimetry Workshop, Denver, Colorado, May 31 June 2, 2006. Antarctica A Keystone in a Changing World. 1 indexed citations
11.
Mandell, Lionel A., Lance R. Peterson, Richard Wise, et al.. (2002). The Battle against Emerging Antibiotic Resistance: Should Fluoroquinolones Be Used to Treat Children?. Clinical Infectious Diseases. 35(6). 721–727. 58 indexed citations
12.
Wise, Richard. (1998). Grepafloxacin: pharmacokinetics and tissue penetration. Clinical Microbiology and Infection. 4. S21–S24. 3 indexed citations
13.
Wise, Richard & Jennifer M. Andrews. (1998). The bactericidal activity of gatifloxacin in plasma and urine. Clinical Microbiology and Infection. 4(7). 392–396. 9 indexed citations
14.
Cook, Peter J., Paul Davies, Richard Wise, & D. Honeybourne. (1998). Chlamydia pneumoniae infection and ethnic origin. Ethnicity and Health. 3(4). 237–246. 7 indexed citations
15.
Wise, Richard, et al.. (1998). Quorum sensing: potential means of treating gram-negative infections?. The Lancet. 351(9106). 848–849. 35 indexed citations
16.
Wise, Richard. (1998). Bioterrorism: thinking the unthinkable. The Lancet. 351(9113). 1378–1378. 11 indexed citations
17.
Cook, Peter J., J. M. Andrews, Richard Wise, & D. Honeybourne. (1996). Distribution of cefdinir, a third generation cephalosporin antibiotic, in serum and pulmonary compartments. Journal of Antimicrobial Chemotherapy. 37(2). 331–339. 23 indexed citations
18.
Brenwald, N., et al.. (1995). Enumeration of phagocytosed Staphylococcus aureus inside cells of the mouse macrophage cell line J774 by bioluminescence, fluorescence and viable counting techniques. Journal of Bioluminescence and Chemiluminescence. 10(5). 291–299. 2 indexed citations
19.
Cook, Peter J., et al.. (1995). Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments. Journal of Antimicrobial Chemotherapy. 35(2). 317–326. 56 indexed citations
20.
Wise, Richard. (1987). ANTIMICROBIAL AGENTS: A WIDENING CHOICE. The Lancet. 330(8570). 1251–1254. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026